Northwire Canada EditionSaturday, July 11, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings Routine +

Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year

TLRY · Price

Executive Summary

  • Tilray Brands reported record Q3 net revenue of $206.7 M (+11% YoY) and a dramatic 73% YoY increase in international cannabis revenue, driving overall net revenue growth.
  • Net loss narrowed sharply to $(25.2 M) versus $(793.5 M) a year earlier, with adjusted EBITDA rising 19% to $10.7 M.
  • The company reaffirmed FY 2026 adjusted EBITDA guidance of $62‑$72 M, highlighted a strong cash position of $264.8 M, and announced the completion of Project 420 delivering ~$33 M annualized cost savings.

Key Details

  • Revenue & Profitability
  • Net revenue: $206.7 M (Q3 2026) vs. $185.8 M (Q3 2025).
  • Gross profit: $55.0 M vs. $52.0 M; gross margin fell slightly to 27% from 28%.
  • Cannabis net revenue: $64.8 M (+19% YoY), driven by a 73% increase in international cannabis sales and an 8% rise in Canadian adult‑use/medical sales.
  • Beverage net revenue declined to $42.6 M (down 24% YoY).
  • Wellness net revenue: $16.4 M (+16%).

  • Segment Performance

  • Cannabis: Gross profit $26.0 M (+18% YoY); gross margin 40% vs. 41% prior year.
  • Distribution (incl. Tilray Pharma): Net revenue $83.0 M, gross profit $10.0 M, margin up to 12%.
  • Beverage: Net revenue $42.6 M, gross profit $13.6 M; margins fell to 32% from 36%.

  • Loss & Adjusted Metrics

  • Net loss: $(25.2 M) vs. $(793.5 M) a year earlier (97% improvement).
  • Adjusted net income: $2.4 M (+$4.8 M YoY); adjusted EPS $0.02 vs. $(0.03).
  • Adjusted EBITDA: $10.7 M (+19%).

  • Balance Sheet & Liquidity

  • Cash, restricted cash & marketable securities: $264.8 M (up from $248.4 M).
  • Net cash position improved to $3.5 M, a $40.2 M swing from a net debt of $36.6 M YoY.
  • Total outstanding debt reduced by $4.2 M during the quarter.

  • Project 420

  • Completed cost‑saving program delivering approximately $33 M annualized savings, primarily within the Beverage business.

  • Guidance & Outlook

  • FY 2026 adjusted EBITDA guidance reaffirmed at $62–$72 M (13%–31% growth vs. FY 2025).
  • Management monitoring geopolitical risks (e.g., Middle‑East hostilities) that could affect logistics and energy costs.

  • Acquisition Note

  • BrewDog acquisition (~£40 M cash) was completed after quarter‑end; not reflected in Q3 results but positions Tilray as a global craft‑beverage player.

Notable Quotes

“Our third quarter results demonstrated the strength of our global strategy… delivering our strongest Q3 net revenue and gross profit to date.” – Irwin D. Simon, Chairman & CEO
“The BrewDog acquisition and upcoming Carlsberg partnership accelerate the build‑out of a scaled global beverage platform…” – Irwin D. Simon

Read the original news release →

More from TILRAY BRANDS, INC. J